BioSpace News Archive

With this expansion of the O3 platform, the benefits of monitoring with O3 are now available to patients of all ages, from neonates to adults.

As allowable, ACS will be applying for all three permit types, creating a vertically integrated model for the business.

The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.

Awarded FDA Breakthrough Device Designation for Immunopheresis™, its non-pharmaceutical solution for treating stage IV metastatic cancer, began treating its first of 170 triple-negative breast cancer (TNBC) patients on Friday, May 31 at the Jagiellonian University Medical College - Hospital in Cracow, Poland.

St. George’s University honored a new class of medical school graduates from 38 countries and bestowed honorary doctorates and service awards on four individuals during its commencement ceremonies earlier this month.

These data support using SelectMDx to help guide initial prostate biopsy decisions

In addition to the development of CELLECTRA 3PSP, the new award will fund the investigation of DNA vaccines developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) using the new device.

170 million people in North and South America have sleep apnea, ResMed study finds Researchers urge more screenings and cloud-connected treatment devices to curb growing health crisis

St. Jude Children’s Research Hospital® raised $300,000 for children with cancer and other life-threatening diseases at the 11th running of the St. Jude Rock ‘n’ Roll Seattle Marathon & ½ Marathon.

The Wisconsin LGBT Chamber of Commerce and Herzing University-Brookfield announced a scholarship for LGBT individuals working in the healthcare industry.